Aromatherapy and the central nerve system (CNS): Therapeutic mechanism and its associated genes

Current Drug Targets

Volumn 14, Issue 8, 2013, Pages 872-879

  Lv, Xiao Nan ^a   Liu, Zhu Jun ^b   Zhang, Huan Jing ^a   Tzeng, Chi Meng ^a  

^a XIAMEN UNIVERSITY   (China)

^b Xiamen Torch Hi Tech Industrial Development Zone   (China)

Author keywords

Aromatherapy; Central nerve system; Essential oils; Psychiatric disorders

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CARVACROL; CYCLIC AMP; DOPAMINE; FLUOXETINE; IMIPRAMINE; IPRONIAZID; LAVENDER OIL; NORADRENALIN; PHOSPHOLIPASE C; PINENE; RESERPINE; SEROTONIN;

ANXIETY; AROMATHERAPY; ARTICLE; BLACK CUMIN; BLOOD BRAIN BARRIER; CENTRAL NERVOUS SYSTEM DISEASE; DAILY LIFE ACTIVITY; DEPRESSION; DISEASE SEVERITY; HEADACHE; HUMAN; HYPERTENSION; INSOMNIA; MICROARRAY ANALYSIS; NAUSEA; NONHUMAN; OLFACTORY DISCRIMINATION; POSITRON EMISSION TOMOGRAPHY; PREVALENCE; PROTEIN PHOSPHORYLATION; RISK FACTOR; SIGNAL TRANSDUCTION; SUICIDE;

AROMATHERAPY; CENTRAL NERVOUS SYSTEM; DEPRESSION; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MOOD DISORDERS; OILS, VOLATILE; OLFACTORY PERCEPTION; RECEPTORS, SEROTONIN; SIGNAL TRANSDUCTION;

EID: 84881342532     PISSN: 13894501     EISSN: 18735592     Source Type: Journal    
DOI: 10.2174/1389450111314080007     Document Type: Article

References (63)

1. Barbara A, Gerhard B. Biological properties of essential oils: an updated review. Flavour Frag J 2010; 25: 407-26.
2. Efferth T, Greten HJ. Medicinal and Aromatic Plant Research in the 21st Century. Med Aromatic Plants 2012; 1: 4.
3. Panel NSotS. National Institutes of Health State-of-the-Science Conference statement: management of menopause-related symptoms. Ann Intern Med 2005; 142: 1003-13.
4. Herz RS. Aromatherapy facts and fictions: a scientific analysis of olfactory effects on mood, physiology and behavior. Int J Neurosci 2009; 119: 263-90.
5. Clara DBG. Actions of essential oils on the central nervous system: An updated review. Flavour and Fragrance Journal 2011; 26: 300-16.
6. Jorm AF, Korten AE, Christensen H, Jacomb PA, Rodgers B, Parslow RA. Association of obesity with anxiety, depression and emotional well-being: a community survey. Aust N Z J Public Health 2003; 27: 434-40.
7. Cooke B, Ernst E. Aromatherapy: a systematic review. Br J Gen Pract 2000; 50: 493-6.
8. Perry N, Perry E. Aromatherapy in the management of psychiatric disorders: clinical and neuropharmacological perspectives. CNS Drugs 2006; 20: 257-80.
9. Komori T, Fujiwara R, Tanida M, Nomura J. Potential antidepressant effects of lemon odor in rats. Eur Neuropsychopharm 1995; 5: 477-80.
10. Lemon K. An assessment of treating depression and anxiety with aromatherapy. Int J Aromatherapy 2004; 14: 63-9.
11. Setzer WN. Essential oils and anxiolytic aromatherapy. Nat Prod Commun 2009; 4: 1305-16.
12. Braden R, Reichow S, Halm MA. The use of the essential oil lavandin to reduce preoperative anxiety in surgical patients. J Perianesth Nurs 2009; 24: 348-55.
13. Hoya Y, Matsumura I, Fujita T, Yanaga K. The use of nonpharmacological interventions to reduce anxiety in patients undergoing gastroscopy in a setting with an optimal soothing environment. Gastroenterol Nurs 2008; 31: 395-9.
14. Kritsidima M, Newton T, Asimakopoulou K. The effects of lavender scent on dental patient anxiety levels: a cluster randomised-controlled trial. Community Dent Oral Epidemiol 2010; 38: 83-7.
15. Chien LW, Cheng SL, Liu CF. The effect of lavender aromatherapy on autonomic nervous system in midlife women with insomnia. Evid Based Complement Alternat Med 2012.
16. Elisabetsky E, Marschener J, Souza DO. Effects of linalool on glutaminergic system in the rat cerebral cortex. Neurochem Res 1995; 20: 461-5.
17. Melo FH, Venancio ET, de Sousa DP, et al. Anxiolytic-like effect of Carvacrol (5-isopropyl-2-methylphenol) in mice: involvement with GABAergic transmission. Fundam Clin Pharmacol 2009; 24: 437-43.
18. Perveen T, Haider S, Kanwal S, Haleem DJ. Repeated administration of Nigella sativa decreases 5-HT turnover and produces anxiolytic effects in rats. Pak J Pharm Sci 2009; 22: 139-44.
19. Fukumoto S, Morishita A, Furutachi K, Terashima T, Nakayama T, Yokogoshi H. Effect of flavour components in lemon essential oil on physical or psychological stress. Stress and Health 2008; 24: 3-12.
20. Kim Y, Kim M, Kim H, Kim K. Effect of lavender oil on motor function and dopamine receptor expression in the olfactory bulb of mice. J Ethnopharmacol 2009; 125: 31-5.
21. Kalueff AV, Nutt DJ. Role of GABA in anxiety and depression. Depress Anxiety 2007; 24: 495-517.
22. Olesen J, Baker MG, Freund T, et al. Consensus document on European brain research. J Neurol Neurosurg Psychiatry 2006; 77 Suppl 1: i1-49.
23. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 34: 13-25.
24. Nutt DJ, Ballenger JC, Sheehan D, Wittchen HU. Generalized anxiety disorder: comorbidity, comparative biology and treatment. Int J Neuropsychopharmacol 2002; 5: 315-25.
25. Yim VW, Ng AK, Tsang HW, Leung AY. A review on the effects of aromatherapy for patients with depressive symptoms. J Altern Complement Med 2009; 15: 187-95.
26. Fava M, Kendler KS. Major depressive disorder. Neuron 2000; 28: 335-41.
27. Pezawas L, Meyer-Lindenberg A, Drabant EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat Neurosci 2005; 8: 828-34.
28. Caspi A, Sugden K, Moffitt TE, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386-9.
29. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455: 894-902.
30. Overstreet DH. Modeling Depression in Animal Models. Methods Mol Biol 2012; 829: 125-44.
31. Ansorge MS, Zhou M, Lira A, Hen R, Gingrich JA. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 2004; 306: 879-81.
32. Riederer P, Lachenmayer L, Laux G. Clinical applications of MAO-inhibitors. Curr Med Chem 2004; 11: 2033-43.
33. Racagni G, Popoli M. Cellular and molecular mechanisms in the long-term action of antidepressants. Dialogues Clin Neurosci 2008; 10: 385-400.
34. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med 2009; 60: 355-66.
35. Moraes FP, de Azevedo WF Jr. Targeting imidazoline site on monoamine oxidase B through molecular docking simulations. J Mol Model 2012; 18: 3877-86.
36. Komiya M, Takeuchi T, Harada E. Lemon oil vapor causes an antistress effect via modulating the 5-HT and DA activities in mice. Behav Brain Res 2006; 172: 240-9.
37. Zhang X, Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science 2004; 305: 217.
38. Ruhe HG, Mason NS, Schene AH. Mood is indirectly related to serotonin, norepinephrine and dopamine levels in humans: a metaanalysis of monoamine depletion studies. Mol Psychiatry 2007; 12: 331-59.
39. Meyer JH, Ginovart N, Boovariwala A, et al. Elevated monoamine oxidase a levels in the brain: an explanation for the monoamine imbalance of major depression. Arch Gen Psychiatry 2006; 63: 1209-16.
40. Sharp T, Cowen PJ. 5-HT and depression: is the glass half-full? Curr Opin Pharmacol 2011; 11: 45-51.
41. Svenningsson P, Chergui K, Rachleff I, et al. Alterations in 5-HT1B receptor function by p11 in depression-like states. Science 2006; 311: 77-80.
42. Tanis KQ, Duman RS. Intracellular signaling pathways pave roads to recovery for mood disorders. Ann Med 2007; 39: 531-44.
43. Duric V, Banasr M, Licznerski P, et al. A negative regulator of MAP kinase causes depressive behavior. Nat Med 2010; 16: 1328-32.
44. Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS. Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry 2005; 57: 1526-34.
45. Coupland NJ, Ogilvie CJ, Hegadoren KM, Seres P, Hanstock CC, Allen PS. Decreased prefrontal Myo-inositol in major depressive disorder. Biol Psychiatry 2005; 57: 1526-34.
46. Valdizan EM, Gutierrez O, Pazos A. Adenylate cyclase activity in postmortem brain of suicide subjects: reduced response to betaadrenergic stimulation. Biol Psychiatry 2003; 54: 1457-64.
47. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacol 2008; 33: 88-109.
48. Blendy JA. The role of CREB in depression and antidepressant treatment. Biol Psychiatry 2006; 59: 1144-50.
49. Schatzberg AF. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J Clin Psychiatry 2007; 68 Suppl 8: 26-34.
50. Rush AJ, Trivedi MH, Wisniewski SR, et al. Acute and longerterm outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163: 1905-17.
51. Field T, Diego M, Hernandez-Reif M, et al. Lavender fragrance cleansing gel effects on relaxation. Int J Neurosci 2005; 115: 207-22.
52. Baron RA. Environmentally Induced Positive Affect: Its Impact on Self-Efficacy, Task Performance, Negotiation, and Conflict. J Appl Soc Psychol 1990; 20: 369-84.
53. Rotton J. Affective and cognitive consequences of malodorous pollution. Basic Appl Soc Psychol 1983; 4: 171-91.
54. Moss M, Cook J, Wesnes K, Duckett P. Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 2003; 113: 15-38.
55. Kovacs T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev 2004; 3: 215-32.
56. Doty RL. Olfaction. Annu Rev Psychol 2001; 52: 423-52.
57. John CL. Olfaction. Leffingwell Reports 2002; 2.
58. Malnic B, Godfrey PA, Buck LB. The human olfactory receptor gene family. Proc Natl Acad Sci USA 2004; 101: 2584-9.
59. Godfrey PA, Malnic B, Buck LB. The mouse olfactory receptor gene family. Proc Natl Acad Sci USA 2004; 101: 2156-61.
60. Buck LB. Unraveling the sense of smell (Nobel lecture). Angew Chem Int Ed Engl 2005; 44: 6128-40.
61. Kuroda K, Inoue N, Ito Y, et al. Sedative effects of the jasmine tea odor and (R)-(-)-linalool, one of its major odor components, on autonomic nerve activity and mood states. Eur J Appl Physiol 2005; 95: 107-14.
62. Wong ST, Trinh K, Hacker B, et al. Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron 2000; 27: 487-97.
63. Schild D, Restrepo D. Transduction mechanisms in vertebrate olfactory receptor cells. Physiol Rev 1998; 78: 429-66.